PROTEON THERAPEUTICS INC - COM (PRTO)

CUSIP: 74371L109

Q1 2015 13F Holders as of 31 Mar 2015

Type / Class
Equity / COM
Total 13F shares
8,033,279
Share change
-19,335
Total reported value
$81,194,437
Price per share
$11.63
Number of holders
20
Value change
-$139,834
Number of buys
6
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 74371L109?
CUSIP 74371L109 identifies PRTO - PROTEON THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PROTEON THERAPEUTICS INC - COM (PRTO) as of Q1 2015

As of 31 Mar 2015, PROTEON THERAPEUTICS INC - COM (PRTO) was held by 20 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,033,279 shares. The largest 10 holders included Abingworth LLP, DEERFIELD MANAGEMENT CO, RA CAPITAL MANAGEMENT, LLC, MPM ASSET MANAGEMENT LLC, FMR LLC, TIVERTON ASSET MANAGEMENT LLC, Devon Park Associates, LLC, PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, and BAKER BROS. ADVISORS LP. This page lists 20 institutional shareholders reporting positions in this security for the Q1 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.